Gurubasavaraja Swamy Purawarga Matada

14PUBLICATIONS
21CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMolecular targetsIndustrial microbiology (incl. biofeedstocks)Human impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 19, 2026
Pyrimidine derivatives as anticancer agents targeting kinases: design strategies, biological evaluation, and structure-activity relationship insights.

|Feb 25, 2026
Medicinal chemistry perspective of chalcone derivatives as anticancer agents: synthetic strategy, biological activity, and structure-activity relationship.

Aryadipto Dasgupta, R Rajesh, Pronoy Kanti Das

|Dec 03, 2025
Steroidal Scaffolds as Anticancer Agents: Evolution, FDA Approvals, Synthetic Derivatives, SAR Profiles, and Translational Perspectives.

Prabhugouda Gugal, Hemalatha Kamurthy, Rohit Pal

|Apr 21, 2025
In-silico based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studies.

Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar

|Jan 30, 2025
Explanatory review on DDR inhibitors: their biological activity, synthetic route, and structure-activity relationship.

Sindhuja Sengupta, Lalmohan Maji, Pronoy Kanti Das

|Jul 26, 2024
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR-Targeted Anticancer Agents.

Ketan R Hosamani, Hemalatha K, Rohit Pal

Pageof 3

Frequent Collaborators

9 joint publications

Rohit Pal

5 joint publications

Prasad Sanjay Dhiwar

5 joint publications

Sindhuja Sengupta

5 joint publications

Lalmohan Maji